Compare UP & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UP | BBNX |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 564.7M | 613.7M |
| IPO Year | N/A | 2025 |
| Metric | UP | BBNX |
|---|---|---|
| Price | $0.73 | $13.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $27.58 |
| AVG Volume (30 Days) | ★ 3.0M | 1.1M |
| Earning Date | 02-19-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $757,468,000.00 | $88,570,000.00 |
| Revenue This Year | $174.46 | $53.88 |
| Revenue Next Year | N/A | $34.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $0.56 | $8.89 |
| 52 Week High | $3.50 | $32.71 |
| Indicator | UP | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 32.17 |
| Support Level | $0.62 | $13.25 |
| Resistance Level | $0.73 | $15.53 |
| Average True Range (ATR) | 0.06 | 1.00 |
| MACD | 0.00 | 0.44 |
| Stochastic Oscillator | 87.58 | 29.08 |
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.